Mark Kay, M.D., Ph.D.
Member, Gene Therapy SAB
Mark A. Kay, M.D., Ph.D., is the Dennis Farrey Family Professor in the Departments of Pediatrics and Genetics, and Head of the Division of Human Gene Therapy in Pediatrics at the Stanford University School of Medicine. Professor Kay received his M.D.-Ph.D. at Case Western Reserve University and completed a residency in pediatrics, fellowship in medical genetics and inborn errors of metabolism, and post-doctoral research at Baylor College of Medicine. Dr. Kay was an assistant/associate professor at the University of Washington in the Department of Medicine from 1993-1998 before moving to Stanford. Dr. Kay’s group has published over 275 papers in leading journals. Dr. Kay is most well-known for his contributions in the field of gene-based therapeutics and non-coding RNA biology specifically related to microRNA biogenesis and tRNA derived small RNAs.
Dr. Kay is one of the founders of the American Society of Gene and Cell Therapy and served as the President in 2005-2006 and received the society’s outstanding investigator award in 2013. In 2021, he was elected to the National Academy of Inventors.